Transfection of the CD63 negative melanoma cell line KM3 with genomic CD63 resulted in cells with similar in vitro growth rates as control cells, but much slower growth rates in vivo when cells were injected intradermally in nude mice [20]. The gene discussed is CD63; the disease is melanoma.